Cargando…
Metformin as an anticancer drug: A Commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578488/ https://www.ncbi.nlm.nih.gov/pubmed/26421142 http://dx.doi.org/10.1111/jdi.12300 |
| _version_ | 1782391124393984000 |
|---|---|
| author | Song, In-Sung Han, Jin Lee, Hong Kyu |
| author_facet | Song, In-Sung Han, Jin Lee, Hong Kyu |
| author_sort | Song, In-Sung |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4578488 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | John Wiley & Sons, Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45784882015-09-29 Metformin as an anticancer drug: A Commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides Song, In-Sung Han, Jin Lee, Hong Kyu J Diabetes Investig Commentaries John Wiley & Sons, Ltd 2015-09 2014-12-05 /pmc/articles/PMC4578488/ /pubmed/26421142 http://dx.doi.org/10.1111/jdi.12300 Text en © 2014 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and Wiley Publishing Asia Pty Ltd http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
| spellingShingle | Commentaries Song, In-Sung Han, Jin Lee, Hong Kyu Metformin as an anticancer drug: A Commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
| title | Metformin as an anticancer drug: A Commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
| title_full | Metformin as an anticancer drug: A Commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
| title_fullStr | Metformin as an anticancer drug: A Commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
| title_full_unstemmed | Metformin as an anticancer drug: A Commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
| title_short | Metformin as an anticancer drug: A Commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
| title_sort | metformin as an anticancer drug: a commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578488/ https://www.ncbi.nlm.nih.gov/pubmed/26421142 http://dx.doi.org/10.1111/jdi.12300 |
| work_keys_str_mv | AT songinsung metforminasananticancerdrugacommentaryonthemetabolicdeterminantsofcancercellsensitivitytoglucoselimitationandbiguanides AT hanjin metforminasananticancerdrugacommentaryonthemetabolicdeterminantsofcancercellsensitivitytoglucoselimitationandbiguanides AT leehongkyu metforminasananticancerdrugacommentaryonthemetabolicdeterminantsofcancercellsensitivitytoglucoselimitationandbiguanides |